4 Jefferies Group CRISPR Therapeutics AG Trades
The first CRISPR Therapeutics AG trade was made in Q4 2022. Since then Jefferies Group bought shares one more times and sold shares on two occasions. The investor sold all their shares in Q1 2024 and doesn't own any shares in CRISPR Therapeutics AG anymore.
Avg closing price
Price range
Sold -1 shares
Q1 2024
Avg closing price
$71.59
Price range
$60.67
-
$89.12
New holding (+1 shares)
Q4 2023
Avg closing price
$55.28
Price range
$38.62
-
$72.18
Sold -4.27 Thousand shares
Q1 2023
Avg closing price
$48.57
Price range
$41.00
-
$56.12
New holding (+4.27 Thousand shares)
Q4 2022
Avg closing price
$53.05
Price range
$39.19
-
$65.67
